Acute Myocardial Infarction and Purpuric Drug Eruption Caused by Erlotinib Combined with Cabozantinib:Report of One Case.
10.3881/j.issn.1000-503X.10652
- Author:
Tao LI
1
;
Li Jing JIA
2
;
Juan ZHANG
1
;
Yi HU
1
Author Information
1. Department of Oncology,the First Medical Center,Chinese PLA General Hospital,Chinese PLA Key Laboratory of Oncology, Ministry of Education Key Laboratory for Tumor-targeting Therapy and Antibody Drugs,Beijing 100853,China.
2. Department of Emergency,the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China.
- Publication Type:Case Reports
- MeSH:
Anilides;
adverse effects;
Drug Eruptions;
etiology;
Drug Therapy, Combination;
adverse effects;
Erlotinib Hydrochloride;
adverse effects;
Humans;
Myocardial Infarction;
chemically induced;
Pyridines;
adverse effects
- From:
Acta Academiae Medicinae Sinicae
2019;41(2):278-282
- CountryChina
- Language:Chinese
-
Abstract:
Multi-target anticancer drugs have a more comprehensive and extensive range of action,and there is an uncertain risk in the combination of two drugs.A case of acute toxicity induced by erlotinib combined with cabozantinib is reported in this article.
